Citigroup
RNXT icon

Citigroup’s RenovoRx RNXT Stock Holding History

Citigroup’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,917
Closed -$3.96K – 6169
2026
Q1 		$3.96K Buy
3,917
+3,916
+391,600% +$3.79K ﹤0.01% 5309
2025
Q4 		$1 Sell
1
-3,059
-100% -$3.06K ﹤0.01% 5988
2025
Q3 		$3.89K Buy
+3,060
New +$3.64K ﹤0.01% 5306
2025
Q1 		– Sell
-384
Closed -$495 – 5902
2024
Q4 		$495 Buy
+384
New +$437 ﹤0.01% 5626

Other funds holding RNXT

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Citigroup's RNXT Position: Q2 2026 in Review

Citigroup sold out of RenovoRx (RNXT) in Q2 2026, closing a stake of 3,917 shares — an estimated $3.96K sold.

Citigroup first reported a position in RNXT in Q4 2024 and held it in 4 quarters. The position peaked at $3.96K in Q1 2026. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Citigroup reported no remaining RenovoRx position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 3,917 RenovoRx shares in Q2 2026, an estimated $3.96K.
  • Citigroup first reported a position in RenovoRx in Q4 2024 and held it in 4 quarters.
  • Citigroup's RenovoRx position peaked at $3.96K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.